0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Communications |

Effect of Genetic Differences in Omeprazole Metabolism on Cure Rates for Helicobacter pylori Infection and Peptic Ulcer

Takahisa Furuta, MD; Kyoichi Ohashi, MD; Takashi Kamata, MD; Misako Takashima, MD; Kazuhiro Kosuge, PhD; Tsunehisa Kawasaki, MD; Hiroyuki Hanai, MD; Takahiro Kubota, MS; Takashi Ishizaki, MD; and Eizo Kaneko, MD
[+] Article and Author Information

From Hamamatsu University School of Medicine and Honda Motor Co., Ltd., Hamamatsu, Japan; and SRL, Inc., and International Medical Center of Japan, Tokyo, Japan. Acknowledgments: The authors thank Yasue Noda for PCR restriction fragment length polymorphism analysis of blood samples and thank endoscopy nurses Kiwako Tsuchiya, Miho Ijiri, Rie Suzuki, Tazuko Suzuki, Kayoko Imada, Terumi Yagi, and Emi Ichise for assistance. Grant Support: By Grants-in-Aid for Scientific Research from the Ministry of Education of Japan (08570577 and 10672149). Requests for Reprints: Takahisa Furuta, MD, First Department of Medicine, Hamamatsu University School of Medicine, 3600, Handa-cho, Hamamatsu 431-3192, Japan; e-mail, furuta@akiha.hama-med.ac.jp. Current Author Addresses: Drs. Furuta, Takashima, Hanai, and Kaneko: First Department of Medicine, Hamamatsu University School of Medicine, 3600, Handa-cho, Hamamatsu 431-3192, Japan.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1998;129(12):1027-1030. doi:10.7326/0003-4819-129-12-199812150-00006
Text Size: A A A

Background: Omeprazole is metabolized by S-mephenytoin 4′-hydroxylase (CYP2C19) in the liver. In persons with a poor-metabolizer genotype for CYP2C19, the therapeutic efficacy of omeprazole may be increased.

Objective: To investigate whether CYP2C19 genotype status is associated with cure rates for Helicobacter pylori infection and peptic ulcer achieved by using dual therapy with omeprazole and amoxicillin.

Design: Prospective cohort study.

Setting: University hospital and health service center in Hamamatsu, Japan.

Patients: 62 patients with peptic ulcer and H. pylori infection.

Intervention: Omeprazole and amoxicillin.

Measurements: CYP2C19 genotype status and cure rates for H. pylori infection and peptic ulcer.

Results: Cure rates for H. pylori infection were 28.6% (95% CI, 13.1% to 48.7%), 60% (CI, 38.6% to 83.0%), and 100% (CI, 66.4% to 100%) in the rapid-, intermediate-, and poor-metabolizer groups, respectively. Healing rates for both duodenal and gastric ulcer in the three groups were roughly parallel with cure rates for H. pylori infection.

Conclusion: The results of the genotyping test for CYP2C19 seem to predict cure of H. pylori infection and peptic ulcer in patients who receive dual therapy with omeprazole and amoxicillin.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)